Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FibroBiologics (FBLG)

FibroBiologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FBLG
DateTimeSourceHeadlineSymbolCompany
30/12/202413:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
23/12/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
23/12/202412:55GlobeNewswire Inc.FibroBiologics Announces $25 Million FinancingNASDAQ:FBLGFibroBiologics Inc
20/12/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
19/11/202414:15GlobeNewswire Inc.FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of SplenomegalyNASDAQ:FBLGFibroBiologics Inc
14/11/202414:15GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based TherapeuticsNASDAQ:FBLGFibroBiologics Inc
12/11/202421:20GlobeNewswire Inc.FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:FBLGFibroBiologics Inc
12/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
29/10/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
29/10/202413:15GlobeNewswire Inc.FibroBiologics Announces Updates for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
28/10/202413:31GlobeNewswire Inc.FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024NASDAQ:FBLGFibroBiologics Inc
18/10/202412:30GlobeNewswire Inc.FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic DiseasesNASDAQ:FBLGFibroBiologics Inc
16/10/202413:15GlobeNewswire Inc.FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent OfficeNASDAQ:FBLGFibroBiologics Inc
11/10/202413:31GlobeNewswire Inc.FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual SummitNASDAQ:FBLGFibroBiologics Inc
30/09/202413:31GlobeNewswire Inc.FibroBiologics to Present at 2024 Cell & Gene Meeting on the MesaNASDAQ:FBLGFibroBiologics Inc
24/09/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
19/09/202413:31GlobeNewswire Inc.FibroBiologics Engages Southern Star Research as CRO in AustraliaNASDAQ:FBLGFibroBiologics Inc
12/09/202413:31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
06/09/202413:31GlobeNewswire Inc.FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBLGFibroBiologics Inc
28/08/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
27/08/202423:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
27/08/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
27/08/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
20/08/202413:31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
15/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
13/08/202420:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FBLGFibroBiologics Inc
13/08/202420:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FBLGFibroBiologics Inc
13/08/202420:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FBLGFibroBiologics Inc
13/08/202420:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FBLGFibroBiologics Inc
13/08/202401:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG